世界*實驗材料供應(yīng)商 Icon Genetics 正式授權(quán)上海起發(fā)為其中國代理， Icon Genetics 在一直是行業(yè)的*,一直為廣大科研客戶提供zui為優(yōu)質(zhì)的產(chǎn)品和服務(wù),上海起發(fā)一直秉承為中國科研客戶帶來的產(chǎn)品，的服務(wù)，簽約 Icon Genetics 就是為了給廣大科研客戶帶來更加完善的產(chǎn)品和服務(wù),您的滿意將是我們zui大的收獲

 Icon Genetics 中國代理, Icon Genetics 上海代理， Icon Genetics 北京代理，Icon Genetics 廣東代理， Icon Genetics 江蘇代理Icon Genetics 湖北代理,Icon Genetics 天津,Icon Genetics 黑龍江代理,Icon Genetics 內(nèi)蒙古代理,Icon Genetics 吉林代理,Icon Genetics 福建代理, Icon Genetics 江蘇代理, Icon Genetics 浙江代理, Icon Genetics 四川代理,

ICON GENETICS discovers and develops new biopharmaceuticals and high-value protein products using green plants as production hosts. We have developed new generation production platforms and product prototypes for pharmaceutical, animal health and chemical biotech markets. We offer new plant engineering technologies which address speed, yield, precision, expression control and safety of transgene management in plants.

ICON GENETICS AG, Munich, Germany has been incorporated in 1999. The Company owned two subsidiaries: ICON GENETICS GmbH, Halle, and ICON GENETICS Inc., NJ, USA. In January 2006, the Company has been acquired by BAYER INNOVATION GmbH, a wholly owned subsidiary of BAYER AG. In January 2007, ICON GENETICS AG has been merged into ICON GENETICS GmbH. In January 2012, ICON has been acquired by NOMAD BIOSCIENCE GmbH, Munich, Germany.

So far, ICON GENETICS has generated over 350 FTE-years of research, filed 44 patent applications and exclusively / non-exclusively in-licensed 11 patents. ICON has published a number of milestone research papers in most important peer-review scientific journals.

ICON has built its own GMP-certified facility. Since 2010, ICON is running phase I clinical trials with its first product – individualized vaccine for non-Hodgkin‘s Lymphoma. ICON has a pipeline of cancer antibodies (including several biobetters) and vaccines.

ICON GENETICS is managed by experienced directors and research managers with extensive knowledge of business and corporate research.

當(dāng)?shù)貢r間2014年8月14日，德國Icon Genetics公司從一種名為本氏煙（nicotiana benthamiana）植物的葉子上提取蛋白和酶，這些蛋白和酶將用于生產(chǎn)ZMapp藥物的抗體，這種藥物或許會對埃博拉病毒產(chǎn)生作用。Icon Genetics構(gòu)建了一個系統(tǒng)，將編碼修飾后抗體的基因?qū)脒@種煙草的葉片當(dāng)中。隨后，葉片會產(chǎn)生預(yù)期的單克隆“植物抗體”蛋白。只需要一周時間，人們就可以大量收獲葉片，并提取和純化蛋白。

公司：www.icongenetics。。ｃｏｍ

我們公司zui大優(yōu)勢是強大的采購，

1：基本什么都能進口，血清，抗體，耗材，還有部分限制進口的，

2：貨品全，現(xiàn)經(jīng)營過700多個品牌，基本所有生物試劑耗材都可以進口，特別是冷偏的產(chǎn)品那就更有優(yōu)勢，

3：提供加急服務(wù)，一般1-2周到貨，超過時限加急費全免

4：價格公道，絕大部分價格有優(yōu)勢，當(dāng)然不能保證100%產(chǎn)品都是,因為意味著沒有服務(wù).

5：良好的信譽，大部分客戶我們提供貨到付款服務(wù)，客戶包括清華，北大 交大 復(fù)旦，中山等100多所大學(xué)，ROCHE，阿斯利康，國藥 ，fisher等500多家公司

6：我們還是Santa,Advanced Biotechnologies Inc, Icon Genetics,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, GePromegaridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,Icon Genetics, Polysciences,prospecbi, QA-BIO,quickzyme,FULLERLABS,INC,sterlitech；sysy,TriLink BioTechnologies,Inc；worthington-biochem,zyagen等幾十家國外公司授權(quán)代理。
7：我們還是invitrogen,qiagen,Icon Geneticsam,sigma;Promega,roche,merck, rnd,BD, GE,pierce,BioLegend等*批發(fā)，歡迎合作。

上海起發(fā)實驗試劑有限公司
：楊建輝
400：
辦公：
*8006

企業(yè):
:http://www.qfbio。。ｃｏｍ/
地址：上海市浦東新區(qū)晨陽路225弄東方現(xiàn)代商業(yè)廣場46號303室(近東亭路)